Systematic Strategy for the Development of Glycosyltransferase Inhibitors: Diversity-Oriented Synthesis of FUT8 Inhibitors

Abstract

Glycans control various biological processes, depending on their structures. Particularly, core fucose, formed by α1,6-fucosyltransferase (FUT8), has a substantial influence on multiple biological processes. In this study, we investigated the development of FUT8 inhibitors with structural elements encompassing both the glycosyl donor (GDP-fucose) and acceptor (N-glycan) of FUT8. To efficiently optimize the structure of FUT8 inhibitors, we employed a strategy involving fragmentation of the target structure, followed by a structure optimization using a diversity-oriented synthesis approach. This study proposes an efficient strategy to accelerate the structural optimization of middle molecules.

Key words

compound libraries - diversity-oriented synthesis - glycosyltransferase - enzyme inhibitor - diversity-oriented synthesis

Publikationsverlauf

Eingereicht: 30. Oktober 2023

Angenommen nach Revision: 04. Dezember 2023

Accepted Manuscript online:
04. Dezember 2023

Artikel online veröffentlicht:
15. Januar 2024

• References and Notes

• 1a Fuster MM, Esko JD. Nat. Rev. Cancer 2005; 5: 526
• 1b van Kooyk Y, Rabinovich GA. Nat. Immunol. 2008; 9: 593
• 1c Lichtenstein RG, Rabinovich GA. Cell Death Differ. 2013; 20: 976
• 1d Reily C, Stewart TJ, Renfrow MB, Novak J. Nat. Rev. Nephrol. 2019; 15: 346
• 1e Smith BA. H, Bertozzi CR. Nat. Rev. Drug Discovery 2021; 20: 217
• 2 Uozumi N, Yanagidani S, Miyoshi E, Ihara Y, Sakuma T, Gao C.-X, Teshima T, Fujii S, Shiba T, Taniguchi N. J. Biol. Chem. 1996; 271: 27810
• 3 Takahashi M, Kuroki Y, Ohtsubo K, Taniguchi N. Carbohydr. Res. 2009; 344: 1387
• 4 Wang X, Inoue S, Gu J, Miyoshi E, Noda K, Li W, Mizuno-Horikawa Y, Nakano M, Asahi M, Takahashi M, Uozumi N, Ihara S, Lee SH, Ikeda Y, Yamaguchi Y, Aze Y, Tomiyama Y, Fujii J, Suzuki K, Kondo A, Shapiro SD, Lopez-Otin C, Kuwaki T, Okabe M, Honke K, Taniguchi N. Proc. Natl. Acad. Sci. U.S.A. 2005; 102: 15791
• 5a Shinkawa T, Nakamura K, Yamane N, Shoji-Hosaka E, Kanda Y, Sakurada M, Uchida K, Anazawa H, Satoh M, Yamasaki M, Hanai N, Shitara K. J. Biol. Chem. 2003; 278: 3466
• 5b Shields RL, Lai J, Keck R, O’Connell LY, Hong K, Meng YG, Weikert SH. A, Presta LG. J. Biol. Chem. 2002; 277: 26733
• 5c Satoh M, Shitara K, Hanai N. Trends Glycosci. Glycotechnol. 2006; 18: 129
• 5d Niwa R, Shoji-Hosaka E, Sakurada M, Shinkawa T, Uchida K, Nakamura K, Matsushima K, Ueda R, Hanai N, Shitara K. Cancer Res. 2004; 64: 2127
• 6 Wang X, Gu J, Ihara H, Miyoshi E, Honke K, Taniguchi N. J. Biol. Chem. 2006; 281: 2572
• 7 Wang X, Fukuda T, Li W, Gao C.-x, Kondo A, Matsumoto A, Miyoshi E, Taniguchi N, Gu J. J. Biochem. 2009; 145: 643
• 8a Bastian K, Scott E, Elliott DJ, Munkley J. Int. J. Mol. Sci. 2021; 22: 455
• 8b Liao C, An J, Yi S, Tan Z, Wang H, Li H, Guan X, Liu J, Wang Q. J. Cancer 2021; 12: 4109
• 9 Miyoshi E, Noda K, Yamaguchi Y, Inoue S, Ikeda Y, Wang W, Ko JH, Uozumi N, Li W, Taniguchi N. Biochim. Biophys. Acta, Gen. Subj. 1999; 1473: 9
• 10a Moriwaki K, Noda K, Furukawa Y, Ohshima K, Uchiyama A, Nakagawa T, Taniguchi N, Daigo Y, Nakamura Y, Hayashi N, Miyoshi E. Gastroenterology 2009; 137: 188
• 10b Tanaka K, Moriwaki K, Yokoi S, Koyama K, Miyoshi E, Fukase K. Bioorg. Med. Chem. 2013; 21: 1074
• 11 Okada M, Chikuma S, Kondo T, Hibino S, Machiyama H, Yokosuka T, Nakano M, Yoshimura A. Cell Rep. 2017; 20: 1017
• 12a Shen N, Lin H, Wu T, Wang D, Wang W, Xie H, Zhang J, Feng Z. Kidney Int. 2013; 84: 64
• 12b Wang N, Deng Y, Liu A, Shen N, Wang W, Du X, Tang Q, Li S, Odeh Z, Wu T, Lin H. Sci. Rep. 2017; 7: 16914
• 13 Gao C, Maeno T, Ota F, Ueno M, Korekane H, Takamatsu S, Shirato K, Matsumoto A, Kobayashi S, Yoshida K, Kitazume S, Ohtsubo K, Betsuyaku T, Taniguchi N. J. Biol. Chem. 2012; 287: 16699
• 14a Kajimoto T, Node M. Synthesis 2009; 3179
• 14b Gloster TM, Vocadlo DJ. Nat. Chem. Biol. 2012; 8: 683
• 15a Tu Z, Lin Y.-N, Lin C.-H. Chem. Soc. Rev. 2013; 42: 4459
• 15b Burkart MD, Vincent SP, Düffels A, Murray BW, Ley SV, Wong C.-H. Bioorg. Med. Chem. 2000; 8: 1937
• 15c Murray BW, Wittmann V, Burkart MD, Hung S.-C, Wong C.-H. Biochemistry 1997; 36: 823
• 15d Luengo JI, Gleason JG. Tetrahedron Lett. 1992; 33: 6911
• 15e Norris AJ, Whitelegge JP, Strouse MJ, Faull KF, Toyokuni T. Bioorg. Med. Chem. Lett. 2004; 14: 571
• 15f Ichikawa Y, Lin YC, Dumas DP, Shen GJ, Garcia-Junceda E, Williams MA, Bayer R, Ketcham C, Walker LE. J. Am. Chem. Soc. 1992; 114: 9283
• 15g Qiao L, Murray BW, Shimazaki M, Schultz J, Wong C.-H. J. Am. Chem. Soc. 1996; 118: 7653
• 15h Wong C.-H, Dumas DP, Ichikawa Y, Koseki K, Danishefsky SJ, Weston BW, Lowe JB. J. Am. Chem. Soc. 1992; 114: 7321
• 15i Mitchell ML, Tian F, Lee LV, Wong C.-H. Angew. Chem. Int. Ed. 2002; 41: 3041
• 15j Carchon G, Chrétien F, Delannoy P, Verbert A, Chapleur Y. Tetrahedron Lett. 2001; 42: 8821
• 15k Lee LV, Mitchell ML, Huang S.-J, Fokin VV, Sharpless KB, Wong C.-H. J. Am. Chem. Soc. 2003; 125: 9588
• 15l Manabe Y, Kasahara S, Takakura Y, Yang X, Takamatsu S, Kamada Y, Miyoshi E, Yoshidome D, Fukase K. Bioorg. Med. Chem. 2017; 25: 2844
• 15m Dai Y, Hartke R, Li C, Yang Q, Liu JO, Wang L.-X. ACS Chem. Biol. 2020; 15: 2662
• 16a Okeley NM, Alley SC, Anderson ME, Boursalian TE, Burke PJ, Emmerton KM, Jeffrey SC, Klussman K, Law C.-L, Sussman D, Toki BE, Westendorf L, Zeng W, Zhang X, Benjamin DR, Senter PD. Proc. Natl. Acad. Sci. U.S.A. 2013; 110: 5404
• 16b Rillahan CD, Antonopoulos A, Lefort CT, Sonon R, Azadi P, Ley K, Dell A, Haslam SM, Paulson JC. Nat. Chem. Biol. 2012; 8: 661
• 16c Kizuka Y, Nakano M, Yamaguchi Y, Nakajima K, Oka R, Sato K, Ren C.-T, Hsu T.-L, Wong C.-H, Taniguchi N. Cell Chem. Biol. 2017; 24: 1467
• 17 Wang M, Zhang Z, Chen M, Lv Y, Tian S, Meng F, Zhang Y, Guo X, Chen Y, Yang M, Li J, Qiu T, Xu F, Li Z, Zhang Q, Yang J, Sun J, Zhang H, Zhang H, Li H, Wang W. Cell Death Dis. 2023; 14: 495
• 18 8: EtONa (1.80 mg, 26.4 μmol) was added to a solution of 4 (2.52 mg, 3.30 μmol) in anhyd EtOH (150 μL) at r.t., and the mixture was stirred for 1 d at 60 °C. Anhyd THF (200 μL) and EtONa (1.90 mg, 27.9 μmol) were at r.t., and the resulting mixture was stirred for 1 d at 60 °C. Additional anhyd THF (150 μL) and EtONa (1.50 mg, 22.0 μmol) were then added at r.t., and the mixture was stirred for 1 d at 60 °C. The mixture was neutralized with DOWEX (50W×8 50–100) at r.t. and then filtered. The filtrate was concentrated in vacuo, and the residue was dissolved in 50% TFA–CH₂Cl₂ (400 μL). The resulting mixture was stirred for 30 min at r.t., then diluted with toluene and azeotroped twice. The residue was purified by reverse-phase HPLC [Cosmosil 5C₁₈-AR-300 4.6 × 250 mm column, 2–24% MeCN–H₂O (linear gradient; 33 min) + 0.1% HCOOH, 1.0 mL/min] to give a colorless oil; yield: 0.38 mg (21%). ¹H NMR (500 MHz, CD₃OD): δ = 8.70 (s, 1 H), 4.60 (q, J = 7.1 Hz, 2 H), 4.26–4.21 (m, 3 H), 4.08 (dt, J = 10.6, 6.0 Hz, 1 H), 3.85 (dt, J = 10.6, 5.9 Hz, 1 H), 3.65–3.59 (m, 2 H), 3.48–3.39 (m, 4 H), 2.61 (t, J = 6.0 Hz, 2 H), 1.98–1.92 (m, 2 H), 1.91–1.84 (m, 2 H), 1.53–1.48 (m, 2 H), 1.46 (t, J = 7.2 Hz, 3 H), 1.25 (d, J = 6.5 Hz, 3 H). HRMS (ESI-Orbitrap): m/z [M – H + 2 Na]⁺ calcd for C₂₁H₃₃N₆Na₂O₉S: 591.1820; found: 591.1819.
• 19a Kötzler MP, Blank S, Bantleon FI, Spillner E, Meyer B. Biochim. Biophys. Acta. Gen. Subj. 2012; 1820: 1915
• 19b Kötzler MP, Blank S, Bantleon FI, Wienke M, Spillner E, Meyer B. ACS Chem. Biol. 2013; 8: 1830
• 19c García-García A, Ceballos-Laita L, Serna S, Artschwager R, Reichardt NC, Corzana F, Hurtado-Guerrero R. Nat. Commun. 2020; 11: 973
• 20a Rostovtsev VV, Green LG, Fokin VV, Sharpless KB. Angew. Chem. Int. Ed. 2002; 41: 2596
• 20b Tornøe CW, Christensen C, Meldal M. J. Org. Chem. 2002; 67: 3057
• 21 21: To a solution of 12 (29.4 μg, 0.05 μmol) in DMSO (5 μL), H₂O (8 μL) and phosphate-buffered saline (10×PBS; 5 μL) were added 17.0 μL (0.05 μmol) of a solution of 15 (0.17 μmol) in H₂O (56.0 μL), 5 μL (0.05 μmol) of a solution of THPTA (4.60 μmol) in H₂O (460 μL), 5 μL (0.05 μmol) of a solution of sodium ascorbate (10.1 μmol) in H₂O (1 mL), and 5 μL (0.05 μmol) of a solution of CuSO₄ (12.5 μmol) in H₂O (1.25 mL) at r.t., and the mixture was stirred for 3 h at 37 °C. The resulting mixture was purified by reverse-phase HPLC [Cosmosil 5C₁₈-AR-300 2.0 × 150 mm column, 5–30% MeCN–H₂O (linear gradient; 50 min) + 0.1% HCOOH, flow rate 0.2 mL/min] to give a white solid; yield: 31.7 μg [28%, estimated by UV (λ = 280 nm) absorption in HPLC analysis]. HRMS (ESI-Orbitrap): m/z [M – 2 H]^2– calcd for C₈₇H₁₃₉N₁₅O₅₂S: 1128.9213; found; 1128.9220.